{
    "2021-10-13": [
        [
            {
                "time": "2021-10-14",
                "original_text": "UPDATE 2-J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study",
                "features": {
                    "keywords": [
                        "J&J",
                        "COVID-19",
                        "shot",
                        "Moderna",
                        "Pfizer",
                        "NIH",
                        "study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Covid-19",
                        "Booster",
                        "Shot",
                        "FDA",
                        "Staff"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Is JNJ Stock A Buy After Asking FDA To Authorize Its Covid Booster Shot?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Stock",
                        "Buy",
                        "FDA",
                        "Authorize",
                        "Covid",
                        "Booster"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Will J&J's Covid Booster Get FDA's Blessing? Here's Why It Looks Likely",
                "features": {
                    "keywords": [
                        "J&J",
                        "Covid",
                        "Booster",
                        "FDA",
                        "Blessing"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Johnson & Johnson Booster Shot May Bolster Immune Response, FDA Staff Says",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Booster",
                        "Shot",
                        "Immune",
                        "Response",
                        "FDA",
                        "Staff"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "U.S. to open Canada, Mexico borders for vaccinated visitors",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Canada",
                        "Mexico",
                        "borders",
                        "vaccinated",
                        "visitors"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "travel",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Pioneered",
                        "Battle",
                        "HIV/AIDS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Americans are losing trust in Bidenâ€™s handling of the COVID pandemic: poll",
                "features": {
                    "keywords": [
                        "Americans",
                        "losing",
                        "trust",
                        "Biden",
                        "COVID",
                        "pandemic",
                        "poll"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "politics",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "FDA Staff Shows Cautious Optimism for J&J's Booster Shot",
                "features": {
                    "keywords": [
                        "FDA",
                        "Staff",
                        "Cautious",
                        "Optimism",
                        "J&J",
                        "Booster",
                        "Shot"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Relying on J&J's analyses to assess vaccine booster dose data -U.S. FDA staff",
                "features": {
                    "keywords": [
                        "J&J",
                        "analyses",
                        "assess",
                        "vaccine",
                        "booster",
                        "dose",
                        "data",
                        "FDA",
                        "staff"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "These quality dividend stocks have a built-in advantage that can keep you ahead of inflation in 2022",
                "features": {
                    "keywords": [
                        "quality",
                        "dividend",
                        "stocks",
                        "advantage",
                        "inflation",
                        "2022"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investments"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "3 Top Healthcare Stocks to Buy Right Now",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Stocks",
                        "Buy",
                        "Right",
                        "Now"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "investments"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "J&J Gains as FDA Says Its Covid Booster Shot Helps Immunity",
                "features": {
                    "keywords": [
                        "J&J",
                        "Gains",
                        "FDA",
                        "Covid",
                        "Booster",
                        "Shot",
                        "Immunity"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Got $1,000? 2 Super-Smart Stocks That Could Make You Richer Over the Next Decade",
                "features": {
                    "keywords": [
                        "$1,000",
                        "Super-Smart",
                        "Stocks",
                        "Richer",
                        "Decade"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investments"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Business",
                        "Review",
                        "Pharmaceuticals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "An FDA Advisory Panel Will Debate Moderna and J&J Boosters This Week",
                "features": {
                    "keywords": [
                        "FDA",
                        "Advisory",
                        "Panel",
                        "Debate",
                        "Moderna",
                        "J&J",
                        "Boosters",
                        "Week"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}